US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist

3.900
-0.010-0.26%

Close Aug 30 16:00 ET

31.68MMarket Cap-882P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

4.56%-6.38M

-40.20%-12.89M

-16.80%-31.1M

-26.90%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.20%-26.62M

-0.26%-5.83M

21.67%-5.52M

Net income from continuing operations

15.45%-7.55M

-42.13%-10.44M

-9.57%-34.03M

-14.67%-9.46M

-14.47%-8.3M

-13.86%-8.93M

4.84%-7.35M

-2.08%-31.06M

-46.20%-8.25M

3.17%-7.25M

Depreciation and amortization

-77.78%2K

-10.20%44K

-48.57%18K

100.00%8K

550.00%9K

-25.00%9K

-77.42%49K

34.62%35K

100.00%4K

Other non cash items

--0

99.26%-1K

-1,407.69%-392K

---30K

---91K

---135K

---136K

---26K

----

Change In working capital

-54.51%782K

-31.34%-3.03M

-53.96%965K

-14.96%1.55M

-99.65%4K

6,511.54%1.72M

-159.55%-2.31M

190.58%2.1M

364.49%1.83M

2,370.00%1.14M

-Change in receivables

140.63%13K

31.82%29K

114.13%13K

13.64%-38K

481.25%61K

-28.00%-32K

414.29%22K

-167.65%-92K

-266.67%-44K

-277.78%-16K

-Change in prepaid assets

53.85%260K

32.04%-437K

38.01%679K

42.39%833K

-32.20%320K

-61.33%169K

35.83%-643K

145.30%492K

135.89%585K

-29.13%472K

-Change in payables and accrued expense

-67.83%509K

-55.48%-2.63M

-83.90%273K

-41.04%757K

-155.52%-377K

509.84%1.58M

-1,519.33%-1.69M

224.34%1.7M

238.66%1.28M

193.66%679K

Cash from discontinued investing activities

Operating cash flow

4.56%-6.38M

-40.20%-12.89M

-16.80%-31.1M

-26.90%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.20%-26.62M

-0.26%-5.83M

21.67%-5.52M

Investing cash flow

Cash flow from continuing investing activities

140.60%1M

194.58%10.74M

154.34%6.17M

5.95M

1.08M

-2.46M

-143.74%-11.36M

-37,760.00%-11.36M

Net PPE purchase and sale

----

--0

----

30.00%-21K

----

Net investment purchase and sale

--0

140.60%1M

194.75%10.74M

154.44%6.17M

--5.95M

--1.08M

---2.46M

---11.34M

--0

Cash from discontinued investing activities

Investing cash flow

--0

140.60%1M

194.58%10.74M

154.34%6.17M

--5.95M

--1.08M

---2.46M

-143.74%-11.36M

-37,760.00%-11.36M

--0

Financing cash flow

Cash flow from continuing financing activities

98.38%-5K

29.84%-576K

256.21%742K

-33.44%-435K

-28,600.00%-574K

-1,616.67%-309K

-327.60%-821K

-475K

-326K

Net common stock issuance

--0

13.33%-585K

251.67%725K

-116.24%-426K

---579K

---305K

---675K

---478K

---197K

Proceeds from stock option exercised by employees

----

-60.67%35K

-29.17%17K

--0

----

27.14%89K

--24K

--35K

Net other financing activities

15.38%-11K

-25.00%-5K

88.94%-26K

--0

94.51%-9K

59.38%-13K

77.78%-4K

10.31%-235K

---21K

---164K

Cash from discontinued financing activities

Financing cash flow

--0

98.38%-5K

29.84%-576K

256.21%742K

-33.44%-435K

-28,600.00%-574K

-1,616.67%-309K

-327.60%-821K

---475K

---326K

Net cash flow

Beginning cash position

-47.37%23.18M

-37.37%35.08M

-40.93%56.01M

-51.73%35.56M

-52.38%37.86M

-49.24%44.04M

-40.93%56.01M

-3.92%94.81M

-26.81%73.67M

-26.17%79.51M

Current changes in cash

-3.30%-6.38M

0.58%-11.9M

46.06%-20.93M

97.29%-479K

60.56%-2.31M

14.78%-6.18M

-48.66%-11.97M

-902.64%-38.8M

-202.33%-17.66M

17.05%-5.85M

End cash Position

-55.63%16.8M

-47.37%23.18M

-37.37%35.08M

-51.73%35.56M

-52.38%37.86M

-49.24%44.04M

-40.93%56.01M

-26.81%73.67M

Free cash flow

4.56%-6.38M

-40.20%-12.89M

-16.71%-31.1M

-26.44%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.22%-26.64M

-0.10%-5.85M

21.67%-5.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	4.56%-6.38M	-40.20%-12.89M	-16.80%-31.1M	-26.90%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.20%-26.62M	-0.26%-5.83M	21.67%-5.52M
Net income from continuing operations	15.45%-7.55M	-42.13%-10.44M	-9.57%-34.03M	-14.67%-9.46M	-14.47%-8.3M	-13.86%-8.93M	4.84%-7.35M	-2.08%-31.06M	-46.20%-8.25M	3.17%-7.25M
Depreciation and amortization	-77.78%2K	-77.78%2K	-10.20%44K	-48.57%18K	100.00%8K	550.00%9K	-25.00%9K	-77.42%49K	34.62%35K	100.00%4K
Other non cash items	--0	99.26%-1K	-1,407.69%-392K	---30K	---91K	---135K	---136K	---26K	----	----
Change In working capital	-54.51%782K	-31.34%-3.03M	-53.96%965K	-14.96%1.55M	-99.65%4K	6,511.54%1.72M	-159.55%-2.31M	190.58%2.1M	364.49%1.83M	2,370.00%1.14M
-Change in receivables	140.63%13K	31.82%29K	114.13%13K	13.64%-38K	481.25%61K	-28.00%-32K	414.29%22K	-167.65%-92K	-266.67%-44K	-277.78%-16K
-Change in prepaid assets	53.85%260K	32.04%-437K	38.01%679K	42.39%833K	-32.20%320K	-61.33%169K	35.83%-643K	145.30%492K	135.89%585K	-29.13%472K
-Change in payables and accrued expense	-67.83%509K	-55.48%-2.63M	-83.90%273K	-41.04%757K	-155.52%-377K	509.84%1.58M	-1,519.33%-1.69M	224.34%1.7M	238.66%1.28M	193.66%679K
Cash from discontinued investing activities
Operating cash flow	4.56%-6.38M	-40.20%-12.89M	-16.80%-31.1M	-26.90%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.20%-26.62M	-0.26%-5.83M	21.67%-5.52M
Investing cash flow
Cash flow from continuing investing activities	0	140.60%1M	194.58%10.74M	154.34%6.17M	5.95M	1.08M	-2.46M	-143.74%-11.36M	-37,760.00%-11.36M	0
Net PPE purchase and sale	----	----	--0	----	----	----	----	30.00%-21K	----	----
Net investment purchase and sale	--0	140.60%1M	194.75%10.74M	154.44%6.17M	--5.95M	--1.08M	---2.46M	---11.34M	---11.34M	--0
Cash from discontinued investing activities
Investing cash flow	--0	140.60%1M	194.58%10.74M	154.34%6.17M	--5.95M	--1.08M	---2.46M	-143.74%-11.36M	-37,760.00%-11.36M	--0
Financing cash flow
Cash flow from continuing financing activities	0	98.38%-5K	29.84%-576K	256.21%742K	-33.44%-435K	-28,600.00%-574K	-1,616.67%-309K	-327.60%-821K	-475K	-326K
Net common stock issuance	--0	--0	13.33%-585K	251.67%725K	-116.24%-426K	---579K	---305K	---675K	---478K	---197K
Proceeds from stock option exercised by employees	----	----	-60.67%35K	-29.17%17K	--0	----	----	27.14%89K	--24K	--35K
Net other financing activities	15.38%-11K	-25.00%-5K	88.94%-26K	--0	94.51%-9K	59.38%-13K	77.78%-4K	10.31%-235K	---21K	---164K
Cash from discontinued financing activities
Financing cash flow	--0	98.38%-5K	29.84%-576K	256.21%742K	-33.44%-435K	-28,600.00%-574K	-1,616.67%-309K	-327.60%-821K	---475K	---326K
Net cash flow
Beginning cash position	-47.37%23.18M	-37.37%35.08M	-40.93%56.01M	-51.73%35.56M	-52.38%37.86M	-49.24%44.04M	-40.93%56.01M	-3.92%94.81M	-26.81%73.67M	-26.17%79.51M
Current changes in cash	-3.30%-6.38M	0.58%-11.9M	46.06%-20.93M	97.29%-479K	60.56%-2.31M	14.78%-6.18M	-48.66%-11.97M	-902.64%-38.8M	-202.33%-17.66M	17.05%-5.85M
End cash Position	-55.63%16.8M	-47.37%23.18M	-37.37%35.08M	-37.37%35.08M	-51.73%35.56M	-52.38%37.86M	-49.24%44.04M	-40.93%56.01M	-40.93%56.01M	-26.81%73.67M
Free cash flow	4.56%-6.38M	-40.20%-12.89M	-16.71%-31.1M	-26.44%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.22%-26.64M	-0.10%-5.85M	21.67%-5.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall